Few things can dominate the biotech news like a major acquisition – and for good reason. Not only do these deals reward innovation and spark excitement for new investments, but they move promising and proven treatments into larger organizations that can deliver them quickly to patients on a global scale. In this session, executives from three of the largest acquisitions of 2023 will share the deeper stories behind their deals. Moderated by a veteran biotech communicator, this session will explore topics from deal origins to negotiations, and from announcement to integration. In addition, these biotech leaders will share the lessons they learned along the way.